Publicacións en colaboración con investigadores/as de University of Auckland (15)

2023

  1. The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The IFOS Consensus

    Laryngoscope

2022

  1. Core outcome set for clinical studies of postoperative ileus after intestinal surgery

    British Journal of Surgery, Vol. 109, Núm. 6, pp. 493-496

  2. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

    European Journal of Cancer, Vol. 173, pp. 178-193

  3. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

    JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572

  4. Management of oral feeding following total laryngectomy around the world: YO-IFOS international study

    Head and Neck, Vol. 44, Núm. 8, pp. 1755-1764

  5. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

    British Journal of Cancer, Vol. 124, Núm. 4, pp. 842-854

  2. Impact of subspecialty training on management of laryngopharyngeal reflux: results of a worldwide survey

    European Archives of Oto-Rhino-Laryngology, Vol. 278, Núm. 6, pp. 1933-1943

  3. Management of Laryngopharyngeal Reflux Around the World: An International Study

    Laryngoscope, Vol. 131, Núm. 5, pp. E1589-E1597

2020

  1. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

  2. International consensus definition of low anterior resection syndrome

    ANZ Journal of Surgery, Vol. 90, Núm. 3, pp. 300-307

  3. International consensus definition of low anterior resection syndrome

    Colorectal Disease, Vol. 22, Núm. 3, pp. 331-341

2019

  1. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    npj Breast Cancer, Vol. 5, Núm. 1

2014

  1. Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 312, Núm. 10, pp. 1006-1015

  2. Erratum: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial (JAMA (2014) 312:10(1006-1015))

    JAMA - Journal of the American Medical Association